Low-dose carboplatin reprograms tumor immune microenvironment through STING signaling pathway and synergizes with PD-1 inhibitors in lung cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Low-dose carboplatin reprograms tumor immune microenvironment through STING signaling pathway and synergizes with PD-1 inhibitors in lung cancer

Published:2021-03 Issue: Volume:500 Page:163-171
ISSN:0304-3835
Container-title:Cancer Letters
language:en
Short-container-title:Cancer Letters

Author:

Zhou Li,Xu Qiuli,Huang Litang,Jin Jiajia,Zuo Xueying,Zhang Qun,Ye Liang,Zhu Suhua,Zhan Ping,Ren Jianan,Lv Tangfeng,Song Yong

Funder

National Natural Science Foundation of China

Natural Science Foundation of Jiangsu Province

Jiangsu Provincial Social Development - Key Projects - Clinical Frontier Technologies

Jiangsu Provincial Social Development - General Program

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference50 articles.

1. Cancer statistics;Siegel;CA A Cancer J. Clin.,2019

2. The biology and management of non-small cell lung cancer;Herbst;Nature,2018

3. Treatment of advanced non-small cell lung cancer in 2018;Doroshow;JAMA oncology,2018

4. A paradigm shift in cancer immunotherapy: from enhancement to normalization;Sanmamed;Cell,2018

5. The blockade of immune checkpoint s in cancer immunotherapy;Pardoll;Nat. Rev. Canc.,2012

Cited by 67 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Left out in the cold: Moving beyond hormonal therapy for the treatment of immunologically cold prostate cancer with CAR T cell immunotherapies;The Journal of Steroid Biochemistry and Molecular Biology;2024-10

2. TBK1 is paradoxical in tumor development: a focus on the pathway mediating IFN-I expression;Frontiers in Immunology;2024-08-05

3. A next-generation STING agonist MSA-2: From mechanism to application;Journal of Controlled Release;2024-07

4. ALKBH5 promotes non-small cell lung cancer progression and susceptibility to anti-PD-L1 therapy by modulating interactions between tumor and macrophages;Journal of Experimental & Clinical Cancer Research;2024-06-14

5. The significance of inflammatory markers in prognosticating the effectiveness and safety of immunotherapy in conjunction with chemotherapy during the primary intervention of advanced non-small cell lung carcinoma;Lung Cancer;2024-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3